Through
5/7
A Penn Medicine-led trial found medications to be neither beneficial or harmful in the treatment of hospitalized patients.
As students return to campus, dining services has adopted measures to support new safety and public health protocols at both residential and retail cafés on campus.
It’s an ethical question many Penn experts are contemplating. One fact is certain, they say: Distribution must not exacerbate disparities and inequities in health care.
With undergraduate Move-in starting Jan. 10, Penn Today offers a practical guide to the process.
Penn Wharton Budget Model expert Richard Prisinzano breaks down what’s in the newly passed stimulus bill, what it means, and explains why many experts don't think that'll be enough to stave off an economic slide in the long run.
Penn Today revisits the lexicon of new definitions and phrases to help make sense of news headlines, public health measures, and everyday discussions about COVID-19.
The Environmental Health and Radiation Safety office plays an important role in keeping Penn safe and healthy. Now, during the COVID-19 crisis, the office has stepped up to support the resumption of on-campus activities.
In a Q&A, Penn Medicine’s James M. Wilson discusses using adeno-associated viral vectors to transport a lab-made antibody cocktail into the body. This method, delivered via nasal spray or mist, has the potential to act as a “bioshield” against SARS-CoV-2.
With rates of diagnoses and death disproportionately affecting racial minorities and low-income workers, experts from the School of Arts & Sciences address how COVID-19 has further exposed already dire health outcome inequalities.
By week’s end, the health system expects to receive about 9,275 doses of the Pfizer vaccine for its frontline teams.
Kathleen Hall Jamieson of the Annenberg Public Policy Center says that the sense of urgency around vaccination has faded as attention on respiratory viruses wanes.
FULL STORY →
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
“Tell Me When It’s Over,” a new book by Paul Offit of the Perelman School of Medicine, chronicles the initial years of the COVID-19 pandemic and the mishaps of public health agencies. Recent surveys by the Annenberg Public Policy Center find that mistrust of vaccines has continued to grow through last fall.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
A survey from the Annenberg Public Policy Center found that more than a third of people are concerned about either themselves or one of their family members contracting either the flu, COVID-19, or RSV.
FULL STORY →